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METHYLCHOLANTHRENE TUMORS IN MICE TREATED WITH
CORTISONE
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IN RELATION TO CARCINOGEN APPLICATION*
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M. J. ROTHSTEIN, M.D. AND MARION B. SULZBERGER, M.D.
OBJECTIVE
In the following we shall report on experiments concerning the question of
whether or not the acceleration in the occurrence of epidermal methyicholan-
threne tumors, observed by us previously in mice treated with cortisone (1—3), is
dependent on the timing of the administration of cortisone in relation to the
carcinogen applications. Among several possibilities, it was, for example, con-
ceivable that this acceleration is not caused by direct action of the steroid, but by
withdrawal of its use; in that case, a stronger acceleration was to be expected
from cortisone administration preceding the course of methylcholanthrene
paintings, than from either concomitant or "overlapping" treatments with
cortisone and methylcholanthrene. It was the attempt at clarifying this quest i'n
and several related points which gave rise to the present study.
The observations made in three of our pertinent experiments will be described
in this presentation.'
METHOD AND MATERIALS
Animals. Female albino mice (383) of the Swiss strain, from Carworth Farms, Inc., New
City, Rockland County, N. Y., three months of age; on unrestricted "Rockland mouse
diet" and intake of water.
Carcinogen. Methyloholanthrene, 0.6% in benzene.
Cortisone. Cortone suspension,2 containing 2.5% cortisone acetate, 0.9% benzyl alcohol—
as preservative, and dispersing material (Tween 80 and Na-carboxy-methylcellulose-—
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Post-Graduate Medical School (Dr. Marion B. Sulzberger, Chairman) and the Skin and
Cancer Unit of the University Hospital.
Thi8 study was made possible by a grant of the United States Public Health Service
(U.S.P.H.S.R.G. C 1379).
All numerical results and presentations were supervised by Dr. R. R. Freudenthal,
statistical consultant, Jackson Heights, N. Y.
With the technical assistance of L. Mandol, B.A., L. Frank, B.A., J. Kallman, B.S.,
M. Cohen, B.S., M. Besen, B.A. and C. Guevara.
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'Another group of pertinent experiments—cortisone administration beginning after, or
shortly prior to termination of the methylcholanthrene applications—was started only
recently; the results will be reported later.
by Merck & Co., Inc., Rahway, N. J.
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concentrations unknown) in physiologic saline solution, was diluted with saline solution
to obtain a 0.17% solution of cortisone acetate; at each administration, 0.25 ml. of this
dilution (containing approximately 20 mgm. cortisone acetate per kg. fasting weight) was
injected subcutaneously. The right and left inguinal areas were injected on alternate days.
Experimental Design.
Experiment I (Cortisone administration concomitant with applications of methyl-
cholanthrene).
The first experiment was designed as a pilot experiment assaying (1) the occurrence of
skin tumors in response to only three methyicholanthrene paintings per week for a period
of three weeks; and (2) any acceleration of this response after concomitant treatment with
cortisone—in order to establish a base-line for appraisal of the results of variations in tim-
ing of the course of cortisone injections in relation to that of the carcinogen applications.
The procedure of hair clipping at the beginning of the experiment, as well as the technic
of painting were the same as described in our previous reports (1—3).
In all mice the shin of the interscapular area was painted with methyicholanthrene
in benzene three times per week, for three consecutive weeks.
The animals were divided in three groups:
Group Ia—49 mice: Cortisone was injected on five consecutive days during each of the
three weeks of painting.
Control experiments were carried out in the two other groups as follows:
Group Ib—48 mice—received injections of the (diluted) vehicle of cortisone (Merck &
Co.)—instead of the cortisone injections.
Group Ic—46 mice—did not receive any injections.
Experimeni8 in which the period of cortisone administration did not coincide with that of
the carcinogen applications:
Experiment II (Cortisone treatment prior to carcinogen applications).
Group ha: Cortisone was injected in 40 mice on five consecutive days during each of
three consecutive weeks. Following termination of the injections, i.e. from the first day of
the fourth week of the experiment, methyleholanthrene was applied to the skin of the inter-
scapular region three times a week, for a total of three consecutive weeks.
Two other groups of 40 mice each were used for control experiments as follows:
Group IIb—Instead of the cortisone injections, injections of the diluted vehicle employed
in Merck's Cortone suspension preceded the three weeks' period of methylcholanthrene
applications.
Group lie: Physiologic saline solution was injected instead of the cortisone suspension;
otherwise the procedure was identical with that employed in groups ha and b.
Experiment III (Period of cortisone treatment overlapping first week of carcinogen
applications).
Group lila: In 40 mice, cortisone was administered by injection for a period of three
weeks, in the manner outlined for our previous experiments. Painting with methylehol-
anthrene, however, was started at the beginning of the third week of treatment with corti-
sone and continued for two weeks after termination of the cortisone injections.
Control groups:
Group 11Th: Forty mice received injections of the (diluted) cortisone dispersing liquid,
instead of the cortisone injections; otherwise, the procedure was the same as that in group
lila.
Group life: Forty mice received injections of physiologic saline solution, instead of the
cortisone injections; otherwise the procedure did not differ from that employed in group
lila.
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RESULTS
Incidence of First Skin Tumors.
Experiment I (Concomitant treatment with cortisone and methylcholan-
threne).
Table I shows the incidence of first skin tumors and the number of mice which
died without skin tumors, in each week of the experiment. The experiment was
discontinued at the end of the 36th week.
The average weight of the mice in each group before and after treatment is recorded
below the table; a considerable drop is apparent in the cortisone group, but this weight was
regained two weeks after the termination of treatment.
The overall incidence of skin tumors was low, in particular when compared
with the range of the incidence usually observed when methylcholanthrene is
applied more frequently or for longer periods of time.
Since distinctive rates in the occurrence of first skin tumors were apparent
in the three groups during different periods of observation, our total 36 weeks
of observation was subdivided into four periods, as indicated by the heavy
vertical lines on Table I:
(1) First two weeks: No tumor formation.
(2) Third, fourth, and fifth week: Skin tumors appeared in eight mice of the
cortisone group (Ta), in only one animal of control group Tb—and in two animals
of control group Ic.
During this period, therefore, the tumor incidence was significantly higher in
the cortisone group than in both control groups.
This difference was made even more significant by the death rate of non-
tumor bearing animals, in as much as eight of the cortisone treated mice died
within the first month of the experiment, whereas no death occurred in the con-
trol groups during the first two periods of observation.
(3) Sixth through 16th week: During these 11 weeks, six of the mice injected
with the suspending liquid of Merck's Cortone suspension developed first tumors
(group Tb), whereas there was only one new tumor bearer in the cortisone group
(Ta) and one in the control group in which injections were omitted (Ic).
(4) Seventeenth through 36th week: During this last period, the incidence of
first skin tumors was similar in all groups (eight new tumor bearers in group Ia, as
well as in group Ic; six new tumors bearers in group Tb).
Evidently, the results were considerably more distinctive regarding the time of
appearance of first tumors than regarding the final proportion of tumor bearers per
group.
Experiments in which the periods of cortisone administration and methyicho-
lanthrene treatment did not coincide:
Table TI shows the weekly number of new tumor bearers and of the mice
which died without skin tumors in each week during the course of experiments
II and III.
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The average weights of the different groups of the mice, recorded at the end of the table,
showed a decline after the injection periods, especially in the cortisone-treated groups
(ha and lila); but this weight was regained two weeks after termination of the injections.
The total period of observation was again subdivided into four periods in order
to emphasize the pertinent differences in the incidence of first tumors observed
in the individual groups.
Experiment II (Cortisone treatment prior to methyicholanthrene applications).
There was no significant difference between the tumor incidence observed in
the group in which the course of cortisone injections was followed by exposure to
the carcinogen (ha) and the incidence observed in either one of the two control
groups (JIb and TIc—injected with the plain vehicle of Merck's cortisone sus-
pension and with saline solution, respectively—prior to the carcinogen applica-
tions). In all three groups, the incidence showed a "scattered" pattern similar to
that observed in the control group of experiment I, in which injections were
omitted (group Ic).
Experiment III (Period of cortisone treatment overlapping first week of
methyicholanthrene applications).
The occurrence of skin tumors was significantly accelerated in the group of
animals in which the three weeks' period of cortisone administration overlapped the
first week of painting with methyicholanthrene (Table II, group lila).
During the four periods of observation, first tumors occurred as follows—in
the three groups of this experiment (see Table II):
(1) First three weeks: No tumor development.
(2) Fourth and fifth week: Skin tumors developed in 12 mice of the cortisone
group (lila), against two tumor bearers in the "vehicle" group (11Th) and one
tumor bearer in the saline group (Tile).
(3) Sixth through 16th week: First skin tumors appeared in six mice of the
cortisone group, in three of the vehicle group, whereas no tumor appeared in the
saline group.
(4) Seventeenth through 36th week: Five additional animals showed tumors
in the vehicie group, while there were one new tumor bearer among the cortisone-
treated—and two among the saline mice.
It is evident, therefore, that the total number of first tumors observed in
group lila, in which the cortisone injections were given two weeks prior to—
and one week coinciding with the first week of painting with methylcholanthrene,
was significantly higher than in the control groups.
The number of tumor bearers of the vehicle group (Tub) somewhat exceeded
that of the saline group (IhIc), but this difference was not significant statistically.
Description of Tumors. Macroscopically, not more than one third of all the mice with
skin tumors in experiment I showed tumors with the characteristics of malignancy, i.e.
with nodular configuration, solid consistency, a broad base, and indurated surroundings.
The other tumors were either papillomatous and pedunculated, or too small for gross-
identification. In experiments II and III, two thirds of the total number of tumor bearers
showed skin tumors with grossly distinctive features of malignancy.
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Microscopically, tumor specimens of 31 mice were examined thus far in experiment I;
the characteristics of prickle cell carcinoma were found in at least one tumor per animal
in 11; and those of sarcoma in one of the 31 mice, whereas benign tumors were found in the
remaining 19 animals. These benign tumors were sebaceous adenomas and/or papillomas.
Since in experiments II and III gross observation is still in progress and histologic speci-
mens of skin tumors thus far have been procured only from animals which either were killed
when there was tumor formation with grossly unmistakable evidence of malignancy—or
had died during the later phase of the experiment, specimens with the microscopic features
of malignancy were obtained in nearly all of these mice: Of 28 animals, 23 had at least one
tumor with the characteristics of prickle cell epithelioma, three had tumors suspect of
prickle cell carcinoma, one was afflicted with sarcoma, and one died with sebaceous
adenoma.
DISCUSSION
Due to the chosen schedule of methyicholanthrene applications, the number
of mice showing a tumor response was relatively small in most of our experi-
mental groups (Tables I and II). As a consequence, the differences observed
between the small numbers of tumor-bearers of certain groups present trends,
rather than findings of statistical significance.
The acceleration in the occurrence of tumors noted after the concomitant
treatment with methyicholanthrene and cortisone (experiment I) is in line with
the results of our previous experiments (1—3).
As was indicated in our previous report (3), comparison of these findings with
the seemingly conflicting observations made by other investigators (Boutwell and
Rusch (4)), Engelbrecht-Holm and Asboe-Hansen (5), Zachariae and Asboc-
Hansen (6), Baserga and Shubik (7), Ghadially and Green (8)) brings out the
importance of the time of treatment with cortisone in relation to the periods of
exposure to the carcinogen and of tumor development; these investigators ob-
tained a reduction in tumor formation by using the steroid not only during the
period of tumor induction, but also for a long time thereafter, or even exclusively
after the induction period.
The fact that the cortisone administration which was stopped prior to the
course of applications of the carcinogen did not result in a significant change in
the incident of tumors (experiment II, Table II) rules out the possibility that
withdrawal of the steroid was responsible for the accelerated tumor incidence
observed in our other cortisone experiments.
The result of experiment II appears comparable with the unaltered tumor response
observed in a somewhat similar experiment by Ghadially and Green, in which external corti-
sone applications were followed immediately by exposure to dimethylbenzanthracene and
subsequent paintings with croton oil (8).
The absence of acceleration in the tumor response in experiment II is in
striking contrast with the significant acceleration noted in experiment III
(Table II, group IIIa)—which reveals the crucial importance of the brief period of
coincidence of cortisone administration and carcinogen applications for the occur-
rence of an accelerated response. Whereas it is unknown whether or not our corti-
sone injections during the two weeks prior to painting with methyicholanthrene
somehow contributed to the acceleration (experiment III), it is apparent that
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the injections during the first of the three weeks of painting were of outstanding sig-
nificance, since certainly no stronger acceleration was observed in the experiment
in which the cortisone injections were combined throughout the three weeks'
period of methyicholanthrene painting (experiment I, Table II). In fact, it
appears conceivable that an effect comparable with the inhibitory influence of
cortisone on growth formation noted by other investigators after prolonged or
"late" administration of the steroid (4, 7, 8) may have set in some time during
the second or third week after start of the carcinogen applications and thus
interfered with further acceleration of the tumor response.
The failure of cortisone to bring forth an acceleration in the tumor response, when
employed prior to the carcinogen applications (experiment II), affords evidence that what-
ever factors may be responsible for the acceleration observed in our other experiments, the
effect quickly subsides after cessation of the administration of the steroid. Pertinent in
this connection—and outstanding among the factors possibly responsible, appear the
peculiar microscopic findings we previously encountered at the pilo-sebaceous organ of
animals subjected to simultaneous administration of cortisone and paintings with methyl-
cholanthrene (2, 9). These microscopic findings, in particular a relative inertia in the re-
growth of hair during cortisone administration (as compared with follicular hyperactivity
in the control animals treated with methylcholanthrene only), did not outlast the period
of steroid treatment. Another indication that cortisone is capable of inactivating the hair
follicles of rodents in a rapidly reversible manner is Castor and Baker's observation that
(male) rats showed complete cessation of hair growth and a decrease in the size of the se-
baceous glands during prolonged external applications of cortisone; but a sudden regrowth
and return to normal after the 180th day of painting, even though the treatment was con-
tinued (10). Our pertinent specific findings regarding the question of an inter-relationship
between the effect of cortisone on the hair-follicular cycle and the accelerated tumor re-
sponse in our experiments will be described in a subsequent report.
The somewhat accelerated tumor response noted in our control groups Tb,
3rd period, and Tub—in which the diluted vehicle of cortisone was injected—
in relation to the response obtained in the other control groups (Ic and Tile
Tables I and II), was unexpected and is not readily explained. In view of the
fact that no similar difference was apparent iii the corresponding groups of
experiment II, in which the injections preceded our course of carcinogen applica-
tions, the trend observed in the two other experiments may be not a chance
occurrence—even though the differences are not statistically significant—but
may perhaps be related to the combined treatment with the vehicle and methyl-
cholanthrene.
Recent findings described by K. Setälä, H. Setäla and P. Hoisti (11) might well shed
light on the mechanism underlying the trend in question. These authors observed a distinct
co-carcinogenic effect of a series of surface active compounds, in particular of non-ionic
detergents including Span 20 (sorbitan monolaurate) and Tween 60 (polyoxyethylene
sorbitan monostearate). Tween 60 was considerably more effective than Span 20. When
applied to the skin of mice for several weeks, these agents produced not only a spectacular
tumor promoting effect in animals subjected to a single painting with dimethyl-benzan-
thracene, but also characteristic histologic alterations of the epidermis ("thickening")
and cutis in animals not subjected to any treatment with a carcinogen. Although under
our experimental conditions presumably only traces of the Tween incorporated in Merck's
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cortisone suspending liquid reached the site of tumor formation, our observation appears
to be in line with the findings of Setala and collaborators, and may thus find a rationale.
SUMMARY
(1) Significant acceleration in the occurrence of epidermal tumors was evident
in mice painted with methyicholanthrene (0.6 %) in benzene three times a week
for three consecutive weeks and concomitantly injected with cortisone (20 mgm/
Kg body weight) five times per week during the three weeks of methyicholan-
threne application.
(2) When cortisone was administered during the first three weeks of the experi-
ment and methyicholanthrene applied during the following three weeks, no
significant difference was observed between the tumor response in the animals
treated with cortisone and that in the control animals. This finding negates the
possibility that the acceleration obtained with cortisone in our earlier experi-
ments was caused by withdrawal of the steroid.
(3) The tumor response was significantly accelerated when the last of the three
weeks of cortisone administration coincided with the first week of painting with
methyicholanthrene.
(4) A slight trend toward acceleration in the tumor response was noted in the
control groups in which the cortisone dispersing liquid was injected instead of
cortisone—and in which the injections were not discontinued prior to treatment
with methylcholanthrene.
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